https://www.selleckchem.com/pr....oducts/fezolinetant.
8; 95% confidence interval (CI) = [1.3; 6.7]), the presence of a physical disability at hospital discharge (aOR = 2.3; 95%CI = [1.2; 4.4]) and the presence of behavioral disorders at hospital-discharge (aOR = 5.9; 95%CI = [1.6; 28.4]). Dexamethasone use was not significantly associated with neuro-functional disability (OR = 0.2; 95%CI = [ 0.1;1.3]). Neuro-functional disability is frequently reported 12months after CABM. Detailed neurological examination at discharge is needed to improve the follow-up. NCT01730690. NCT01730690.G
Like
Comment
Share
